{"uid":"62214b61668348ac","name":"TEST-SPO-116378.01","historyId":"METTA-WAM-ISSUE-116:METTA-WAM-ISSUE-116#TEST-SPO-116378.01","time":{"start":1731440836000,"stop":1731440884796,"duration":48796},"status":"passed","flaky":false,"newFailed":false,"newBroken":false,"newPassed":false,"retriesCount":0,"retriesStatusChange":false,"beforeStages":[],"testStage":{"steps":[{"name":"<![CDATA[","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"<a href=\"https://trueagi-io.github.io/metta-wam/reports/tests_output/baseline-compat/tests/baseline_compat/anti-regression/issues/metta-wam-issue-116/test_spo_116378.metta.0_failed.html#METTA-WAM-ISSUE-116.TEST-SPO-116378.01\">Test Report</a>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Assertion: (assertEqualToResult (match &hald116378 (Doxorubicin $p $o) (Doxorubicin $p $o)))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Expected: ((Doxorubicin needed Cardiotoxicity) (Doxorubicin treat Rituximab) (Doxorubicin prolong Neoplasms) (Doxorubicin show Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin show Neoplasms) (Doxorubicin show Glioma) (Doxorubicin exhibit Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin exhibit Neoplasms) (Doxorubicin accumulate Brain_Neoplasms) (Doxorubicin monitor Neoplasms) (Doxorubicin sever Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin given Hemangiosarcoma) (Doxorubicin differ Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin elevated Trastuzum...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Actual: ((Doxorubicin stratify Liposarcoma) (Doxorubicin associated MIR375) (Doxorubicin elevated Trastuzumab) (Doxorubicin include Trastuzumab) (Doxorubicin associated Cardiotoxicity) (Doxorubicin accepted 'Lymphoma,_B-Cell') (Doxorubicin represent Breast_Neoplasms) (Doxorubicin combine Breast_Neoplasms) (Doxorubicin fit Breast_Neoplasms) (Doxorubicin lead Death) (Doxorubicin cause Cardiotoxicity) (Doxorubicin stimulate Ischemia) (Doxorubicin induce CDKN2A) (Doxorubicin affect Cardiomyopathies) (Doxorubicin evaluate CAT) (Doxorubicin evaluate GSR) (Doxorubicin evaluate Lipid_Peroxides) (Doxorubicin e...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"]]>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false}],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":7,"attachmentsCount":0,"hasContent":true,"attachmentStep":false},"afterStages":[],"labels":[{"name":"resultFormat","value":"junit"},{"name":"suite","value":"METTA-WAM-ISSUE-116"},{"name":"testClass","value":"METTA-WAM-ISSUE-116"},{"name":"package","value":"METTA-WAM-ISSUE-116"}],"parameters":[],"links":[],"hidden":false,"retry":false,"extra":{"severity":"normal","retries":[],"categories":[],"history":{"statistic":{"failed":0,"broken":0,"skipped":0,"passed":27,"unknown":0,"total":27},"items":[{"uid":"14e8bacae9418821","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/488//#testresult/14e8bacae9418821","status":"passed","time":{"start":1731436993000,"stop":1731437040606,"duration":47606}},{"uid":"d3f6e841f3cd5dfd","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/487//#testresult/d3f6e841f3cd5dfd","status":"passed","time":{"start":1731395807000,"stop":1731395855177,"duration":48177}},{"uid":"131ac9c004ccf3de","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/486//#testresult/131ac9c004ccf3de","status":"passed","time":{"start":1731395760000,"stop":1731395807934,"duration":47934}},{"uid":"eacd0710894c426c","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/484//#testresult/eacd0710894c426c","status":"passed","time":{"start":1731327080000,"stop":1731327127756,"duration":47756}},{"uid":"e66c4c750b30cdd9","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/483//#testresult/e66c4c750b30cdd9","status":"passed","time":{"start":1731324586000,"stop":1731324633719,"duration":47719}},{"uid":"ce6d124cd70ac740","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/479//#testresult/ce6d124cd70ac740","status":"passed","time":{"start":1731092585000,"stop":1731092633690,"duration":48690}},{"uid":"80026b97de7bfb05","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/478//#testresult/80026b97de7bfb05","status":"passed","time":{"start":1731088957000,"stop":1731089004414,"duration":47414}},{"uid":"abebd6930db65e59","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/477//#testresult/abebd6930db65e59","status":"passed","time":{"start":1731087852000,"stop":1731087899505,"duration":47505}},{"uid":"b7b38c99a787626d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/476//#testresult/b7b38c99a787626d","status":"passed","time":{"start":1731087440000,"stop":1731087488612,"duration":48612}},{"uid":"9dc5319a4b600c04","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/475//#testresult/9dc5319a4b600c04","status":"passed","time":{"start":1731075423000,"stop":1731075471600,"duration":48600}},{"uid":"8c1dd1264efede6b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/474//#testresult/8c1dd1264efede6b","status":"passed","time":{"start":1731074987000,"stop":1731075035151,"duration":48151}},{"uid":"69b7cb529756a4fd","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/472//#testresult/69b7cb529756a4fd","status":"passed","time":{"start":1730979899000,"stop":1730979946818,"duration":47818}},{"uid":"83e4d78ba6ad0743","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/470//#testresult/83e4d78ba6ad0743","status":"passed","time":{"start":1730934931000,"stop":1730934979628,"duration":48628}},{"uid":"936d27d1afc4f78","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/469//#testresult/936d27d1afc4f78","status":"passed","time":{"start":1730921108000,"stop":1730921156633,"duration":48633}},{"uid":"356cec3261d53400","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/468//#testresult/356cec3261d53400","status":"passed","time":{"start":1730914105000,"stop":1730914153095,"duration":48095}},{"uid":"97be4268f3e55db8","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/466//#testresult/97be4268f3e55db8","status":"passed","time":{"start":1730835430000,"stop":1730835478133,"duration":48133}},{"uid":"68a64dd38894b553","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/465//#testresult/68a64dd38894b553","status":"passed","time":{"start":1730776953000,"stop":1730777000601,"duration":47601}},{"uid":"36a2b8318baa1f88","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/464//#testresult/36a2b8318baa1f88","status":"passed","time":{"start":1730776852000,"stop":1730776900757,"duration":48757}},{"uid":"f2c7c092951e06bc","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/462//#testresult/f2c7c092951e06bc","status":"passed","time":{"start":1730757740000,"stop":1730757788155,"duration":48155}},{"uid":"7b4bc60fa4c65f46","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/461//#testresult/7b4bc60fa4c65f46","status":"passed","time":{"start":1730747134000,"stop":1730747182675,"duration":48675}}]},"tags":[]},"source":"62214b61668348ac.json","parameterValues":[]}